首页/数据集/Transcriptional responses of control and MDV3100 resistant lines to DMSO or MDV3100

Transcriptional responses of control and MDV3100 resistant lines to DMSO or MDV3100

ChEBI2013-09-30 更新2026-07-21 收录

耐药性前列腺癌

转录组药物响应

数据链接：

https://www.ebi.ac.uk/biostudies/ArrayExpress/studies/E-GEOD-44927 数据链接链接失效反馈

官方服务：

资源简介：

Transcriptional responses of control and MDV3100 resistant lines to DMSO or MDV3100

应用场景：

创建时间：

2013-09-30

耐药性前列腺癌

激素受体靶向治疗

Constitutively active androgen receptor (AR) signaling confers resistance to AR-targeted therapies. Here we show that the ubiquitin-mediated proteolysis pathway plays a critical role in the degradatio

NIAID Data Ecosystem50

Analysis of pancreatic cancer mouse models treated with SenFer

肿瘤微环境

转录组药物响应

Pancreatic cancer is the seventh leading cause of cancer death worldwide. The prognosis is extremely poor because of the difficulty of early detection, and as a typical example of an intractable cance

NIAID Data Ecosystem10

Integrative transcriptome analysis identifies genes and pathways associated with enzalutamide resistance of prostate cancer

耐药性前列腺癌

转录组分析

Details of Integrative transcriptome analysis of prostate cancer with enzalutamide resistance

NIAID Data Ecosystem10

Supplementary Data S12 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors

耐药性前列腺癌

肿瘤基因组学

Supplementary data 12 describes the GSEA analysis of resistant samples vs baseline samples from patients with acquired resistance

Figshare2023-07-19 更新40

Table S2 from ZNF397 Deficiency Triggers TET2-Driven Lineage Plasticity and AR-Targeted Therapy Resistance in Prostate Cancer